Results 51 to 60 of about 13,315 (221)

Anatomopathological Characterization of the Main Ocular Lesions in Green Turtles (Chelonia mydas) Along the Northern Coast of Bahia, Brazil

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Objective This study aimed to identify and report ophthalmic and adnexal diseases found in specimens of the Green sea turtle (Chelonia mydas). Animal Studied and Procedures Thirty‐nine animals stranded on the beaches of the north coast of Bahia, Brazil were submitted to necropsy.
Danielle Nascimento Silva, José Luís Catão‐Dias, Wendell Marcelo de Souza Perinotto, Matheus Vilardo Loés Moreira, Nayone Lantyer‐Araujo, Pedro Enrique Navas Suárez, Gustavo Rodamilans Macedo, Thaís Pires, Arianne Pontes Oriá, Alessandra Estrela‐Lima   +9 more
wiley   +1 more source

Therapeutic targets for fibro-inflammation in Graves’ orbitopathy

Taiwan Journal of Ophthalmology
Graves’ orbitopathy (GO), a complex autoimmune disorder, remains the most common extrathyroidal manifestation of Graves’ disease. Its pathogenesis is characterized by a progressive transition from inflammation to fibrosis, leading to debilitating ocular ...
Young Jae Kang, Jin Sook Yoon
doaj   +1 more source

Clinical Case of the Combined Course of Diffuse Toxic Goiter and Autoimmune Ophthalmopathy

Mìžnarodnij Endokrinologìčnij Žurnal, 2014
The article presents the experience of treating a patient with diffuse toxic goiter in conjunction with autoimmune ophthalmopathy, about what the patient took thyrostatic drugs, β-blockers, systemic glucocorticoids.
Ye.N. Martsinik, T.V. Chursinova, V.N. Serdyuk, L.N. Pastarus, T.L. Krainyak   +4 more
doaj   +1 more source

Differential Gene Expression Profiling of Orbital Adipose Tissue in Thyroid Orbitopathy [PDF]

, 2015
Published under a Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode)PURPOSE. We aimed to determine differentially expressed genes relevant to orbital inflammation and orbital fat
Burdon, Kathryn Penelope, Craig, Jamie E, Ebeling, Peter R, Hardy, Thomas G, Jung, Chol-Hee, Khong, Jwu Jin, Llamas, Bastien, McNab, Alan A, Selva, Dinesh, Sharma, Shiwani, Smyth, Gordon K, Wang, Lynn Yuning   +11 more
core   +1 more source

Teprotumumab for Thyroid Eye Disease: Efficacy and Impact on Orbital Decompression Utilization

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 1, February 2026.
Teprotumumab has been proven effective in thyroid eye disease and associated exophthalmos management. Since its FDA approval in 2020, teprotumumab therapy has been a popular choice for managing exophthalmos which has resulted in decreased utilization of orbital decompression surgery, from 36.8% between 2015 and 2020 to 11.1% TED patients between 2020 ...
Nitish Kumar, Pedro Lança Gomes, Gaurav Jategaonkar, Michael J. Marino, Amar Miglani, Devyani Lal   +5 more
wiley   +1 more source

MODERN APPROACHES TO THE THERAPY OF ENDOCRINE OPHTHALMOPATHY

Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2019
Background: The number of patients with thyroid disease is increasing due to people suffering from Graves' disease, which is often accompanied by endocrine autoimmune ophthalmopathy.
Nikonova L. V., Tishkovskiy S. V., Hadomskaya V. I., Davydchyk E. V., Doroshkevich I. P.   +4 more
doaj   +1 more source

The psychosocial and clinical outcomes following orbital decompression surgery for thyroid eye disease and predictors of change in quality of life [PDF]

, 2015
Objective: Thyroid eye disease (TED) has been found to reduce quality of life for many patients due to changes in their appearance and vision, although some appear to adjust better than others. This study was designed to investigate whether a patient’s
Ezra, D. G., Hirani, S. P., McBain, H. B., Newman, S. P., Rose, G. E., Wickwar, S.   +5 more
core   +1 more source

Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease

Acta Ophthalmologica, Volume 104, Issue 1, Page e28-e38, February 2026.
Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset, Roy Miodini Nilsen, Kristian Løvås, Kathrine Halsøy, Håkon Reikvam, Ann‐Elin Meling Stokland, Grethe Åstrøm Ueland, Anette S. B. Wolff, Hans Christian D. Aass, Sjur Reppe, Eystein Sverre Husebye, Eyvind Rødahl, Tor Paaske Utheim, Hans Olav Ueland   +13 more
wiley   +1 more source

Total Thyroidectomy for the Treatment of Recurrent Graves' Disease With Ophthalmopathy

Asian Journal of Surgery, 2008
Objective: To determine the outcome of recurrent Graves’ disease with ophthalmopathy (GO) following bilateral total thyroidectomy (TT) in patients with no history of anti-inflammatory treatment with steroids or radioactive iodine treatment. Methods: From
Ahmet Nart, Adam Uslu, Ahmet Aykas, Fatih Yüzbaşoğlu, Murat Doğan, Özgür Demirtaş, Cenk Şimşek   +6 more
doaj   +1 more source

The influence of hepatitis C infection and interferon-α therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report [PDF]

, 2009
Background Hepatitis C virus is a highly immunogenic pathogen often inducing autoimmune activation changes and this can often be further exacerbated by Interferon therapy.
Huy A Tran, Glenn EM Reeves
core   +1 more source